P107 in the public eye: An Rb understudy and more

Cell Division

Volumn 5, Issue , 2010, Pages

  Wirt, Stacey E ^a   Sage, Julien ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MUS;

EID: 77950523935     PISSN: None     EISSN: 17471028     Source Type: Journal    
DOI: 10.1186/1747-1028-5-9     Document Type: Article

References (143)

1. Dryja TP, Friend S, Weinberg RA. Genetic sequences that predispose to retinoblastoma and osteosarcoma. Symp Fundam Cancer Res 1986, 39:115-119.
2. Friend SH, Bernards R, Rogelj S, Weinberg RA, Rapaport JM, Albert DM, Dryja TP. A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature 1986, 323:643-646. 10.1038/323643a0, 2877398.
3. Lee WH, Bookstein R, Hong F, Young LJ, Shew JY, Lee EY. Human retinoblastoma susceptibility gene: cloning, identification, and sequence. Science 1987, 235:1394-1399. 10.1126/science.3823889, 3823889.
4. Lee WH, Shew JY, Hong FD, Sery TW, Donoso LA, Young LJ, Bookstein R, Lee EY. The retinoblastoma susceptibility gene encodes a nuclear phosphoprotein associated with DNA binding activity. Nature 1987, 329:642-645. 10.1038/329642a0, 3657987.
5. Burkhart DL, Sage J. Cellular mechanisms of tumour suppression by the retinoblastoma gene. Nat Rev Cancer 2008, 8:671-682. 10.1038/nrc2399, 18650841.
6. Whyte P, Buchkovich KJ, Horowitz JM, Friend SH, Raybuck M, Weinberg RA, Harlow E. Association between an oncogene and an anti-oncogene: the adenovirus E1A proteins bind to the retinoblastoma gene product. Nature 1988, 334:124-129. 10.1038/334124a0, 2968522.
7. DeCaprio JA, Ludlow JW, Figge J, Shew JY, Huang CM, Lee WH, Marsilio E, Paucha E, Livingston DM. SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene. Cell 1988, 54:275-283. 10.1016/0092-8674(88)90559-4, 2839300.
8. Horowitz JM, Yandell DW, Park SH, Canning S, Whyte P, Buchkovich K, Harlow E, Weinberg RA, Dryja TP. Point mutational inactivation of the retinoblastoma antioncogene. Science 1989, 243:937-940. 10.1126/science.2521957, 2521957.
9. Dyson N, Howley PM, Munger K, Harlow E. The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 1989, 243:934-937. 10.1126/science.2537532, 2537532.
10. Munger K, Werness BA, Dyson N, Phelps WC, Harlow E, Howley PM. Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product. EMBO J 1989, 8:4099-4105. 401588, 2556261.
11. Ewen ME, Ludlow JW, Marsilio E, DeCaprio JA, Millikan RC, Cheng SH, Paucha E, Livingston DM. An N-terminal transformation-governing sequence of SV40 large T antigen contributes to the binding of both p110Rb and a second cellular protein, p120. Cell 1989, 58:257-267. 10.1016/0092-8674(89)90840-4, 2526683.
12. Dyson N, Buchkovich K, Whyte P, Harlow E. The cellular 107K protein that binds to adenovirus E1A also associates with the large T antigens of SV40 and JC virus. Cell 1989, 58:249-255. 10.1016/0092-8674(89)90839-8, 2546678.
13. Harlow E, Whyte P, Franza BR, Schley C. Association of adenovirus early-region 1A proteins with cellular polypeptides. Mol Cell Biol 1986, 6:1579-1589. 367684, 2431282.
14. Claudio PP, Tonini T, Giordano A. The retinoblastoma family: twins or distant cousins?. Genome Biol 2002, 3:reviews3012. 10.1186/gb-2002-3-9-reviews3012, 139411, 12225593.
15. Fang SC, Umen JG. A suppressor screen in chlamydomonas identifies novel components of the retinoblastoma tumor suppressor pathway. Genetics 2008, 178:1295-1310. 10.1534/genetics.107.085977, 2278067, 18385113.
16. Cooper K. Rb, whi it's not just for metazoans anymore. Oncogene 2006, 25:5228-5232. 10.1038/sj.onc.1209630, 16936741.
17. Costanzo M, Nishikawa JL, Tang X, Millman JS, Schub O, Breitkreuz K, Dewar D, Rupes I, Andrews B, Tyers M. CDK activity antagonizes Whi5, an inhibitor of G1/S transcription in yeast. Cell 2004, 117:899-913. 10.1016/j.cell.2004.05.024, 15210111.
18. De Bruin RA, McDonald WH, Kalashnikova TI, Yates J, Wittenberg C. Cln3 activates G1-specific transcription via phosphorylation of the SBF bound repressor Whi5. Cell 2004, 117:887-898. 10.1016/j.cell.2004.05.025, 15210110.
19. Sabelli PA, Larkins BA. Grasses like mammals? Redundancy and compensatory regulation within the retinoblastoma protein family. Cell Cycle 2006, 5:352-355.
20. Lendvai A, Pettko-Szandtner A, Csordas-Toth E, Miskolczi P, Horvath GV, Gyorgyey J, Dudits D. Dicot and monocot plants differ in retinoblastoma-related protein subfamilies. J Exp Bot 2007, 58:1663-1675. 10.1093/jxb/erm022, 17389586.
21. Lu X, Horvitz HR. lin-35 and lin-53, two genes that antagonize a C. elegans Ras pathway, encode proteins similar to Rb and its binding protein RbAp48. Cell 1998, 95:981-991. 10.1016/S0092-8674(00)81722-5, 9875852.
22. Stevaux O, Dimova D, Frolov MV, Taylor-Harding B, Morris E, Dyson N. Distinct mechanisms of E2F regulation by Drosophila RBF1 and RBF2. EMBO J 2002, 21:4927-4937. 10.1093/emboj/cdf501, 126297, 12234932.
23. Heuvel S, Dyson NJ. Conserved functions of the pRB and E2F families. Nat Rev Mol Cell Biol 2008, 9:713-724. 10.1038/nrm2469, 18719710.
24. Du W, Dyson N. The role of RBF in the introduction of G1 regulation during Drosophila embryogenesis. EMBO J 1999, 18:916-925. 10.1093/emboj/18.4.916, 1171184, 10022834.
25. Dimova DK, Stevaux O, Frolov MV, Dyson NJ. Cell cycle-dependent and cell cycle-independent control of transcription by the Drosophila E2F/RB pathway. Genes Dev 2003, 17:2308-2320. 10.1101/gad.1116703, 196467, 12975318.
26. Smith EJ, Leone G, Nevins JR. Distinct mechanisms control the accumulation of the Rb-related p107 and p130 proteins during cell growth. Cell Growth Differ 1998, 9:297-303.
27. Zhu L, Xie E, Chang LS. Differential roles of two tandem E2F sites in repression of the human p107 promoter by retinoblastoma and p107 proteins. Mol Cell Biol 1995, 15:3552-3562. 230592, 7791762.
28. Lynch M, Conery JS. The evolutionary fate and consequences of duplicate genes. Science 2000, 290:1151-1155. 10.1126/science.290.5494.1151, 11073452.
29. Nowak MA, Boerlijst MC, Cooke J, Smith JM. Evolution of genetic redundancy. Nature 1997, 388:167-171. 10.1038/40618, 9217155.
30. Force A, Lynch M, Pickett FB, Amores A, Yan YL, Postlethwait J. Preservation of duplicate genes by complementary, degenerative mutations. Genetics 1999, 151:1531-1545. 1460548, 10101175.
31. Ewen ME, Xing YG, Lawrence JB, Livingston DM. Molecular cloning, chromosomal mapping, and expression of the cDNA for p107, a retinoblastoma gene product-related protein. Cell 1991, 66:1155-1164. 10.1016/0092-8674(91)90038-Z, 1833063.
32. Kiess M, Gill RM, Hamel PA. Expression and activity of the retinoblastoma protein (pRB)-family proteins, p107 and p130, during L6 myoblast differentiation. Cell Growth Differ 1995, 6:1287-1298.
33. Beijersbergen RL, Carlee L, Kerkhoven RM, Bernards R. Regulation of the retinoblastoma protein-related p107 by G1 cyclin complexes. Genes Dev 1995, 9:1340-1353. 10.1101/gad.9.11.1340, 7797074.
34. Mayol X, Garriga J, Grana X. Cell cycle-dependent phosphorylation of the retinoblastoma-related protein p130. Oncogene 1995, 11:801-808.
35. Mayol X, Garriga J, Grana X. G1 cyclin/CDK-independent phosphorylation and accumulation of p130 during the transition from G1 to G0 lead to its association with E2F-4. Oncogene 1996, 13:237-246.
36. Burkhart DL, Viatour P, Ho VM, Sage J. GFP reporter mice for the retinoblastoma-related cell cycle regulator p107. Cell Cycle 2008, 7:2544-2552. 2730771, 18719374.
37. Garriga J, Limon A, Mayol X, Rane SG, Albrecht JH, Reddy EP, Andres V, Grana X. Differential regulation of the retinoblastoma family of proteins during cell proliferation and differentiation. Biochem J 1998, 333(Pt 3):645-654. 1219628, 9677324.
38. Verona R, Moberg K, Estes S, Starz M, Vernon JP, Lees JA. E2F activity is regulated by cell cycle-dependent changes in subcellular localization. Mol Cell Biol 1997, 17:7268-7282. 232584, 9372959.
39. Puri PL, Cimino L, Fulco M, Zimmerman C, La Thangue NB, Giordano A, Graessmann A, Levrero M. Regulation of E2F4 mitogenic activity during terminal differentiation by its heterodimerization partners for nuclear translocation. Cancer Res 1998, 58:1325-1331.
40. Kennedy BK, Barbie DA, Classon M, Dyson N, Harlow E. Nuclear organization of DNA replication in primary mammalian cells. Genes Dev 2000, 14:2855-2868. 10.1101/gad.842600, 317063, 11090133.
41. Zini N, Trimarchi C, Claudio PP, Stiegler P, Marinelli F, Maltarello MC, La Sala D, De Falco G, Russo G, Ammirati G, et al. pRb2/p130 and p107 control cell growth by multiple strategies and in association with different compartments within the nucleus. J Cell Physiol 2001, 189:34-44. 10.1002/jcp.1135, 11573202.
42. Sage J, Miller AL, Perez-Mancera PA, Wysocki JM, Jacks T. Acute mutation of retinoblastoma gene function is sufficient for cell cycle re-entry. Nature 2003, 424:223-228. 10.1038/nature01764, 12853964.
43. Schneider JW, Gu W, Zhu L, Mahdavi V, Nadal-Ginard B. Reversal of terminal differentiation mediated by p107 in Rb-/- muscle cells. Science 1994, 264:1467-1471. 10.1126/science.8197461, 8197461.
44. Robanus-Maandag E, Dekker M, Valk M, Carrozza ML, Jeanny JC, Dannenberg JH, Berns A, te Riele H. p107 is a suppressor of retinoblastoma development in pRb-deficient mice. Genes Dev 1998, 12:1599-1609. 10.1101/gad.12.11.1599, 316874, 9620848.
45. Hurford RK, Cobrinik D, Lee MH, Dyson N. pRB and p107/p130 are required for the regulated expression of different sets of E2F responsive genes. Genes Dev 1997, 11:1447-1463. 10.1101/gad.11.11.1447, 9192872.
46. Callaghan DA, Dong L, Callaghan SM, Hou YX, Dagnino L, Slack RS. Neural precursor cells differentiating in the absence of Rb exhibit delayed terminal mitosis and deregulated E2F 1 and 3 activity. Dev Biol 1999, 207:257-270. 10.1006/dbio.1998.9162, 10068462.
47. Mayhew CN, Bosco EE, Fox SR, Okaya T, Tarapore P, Schwemberger SJ, Babcock GF, Lentsch AB, Fukasawa K, Knudsen ES. Liver-specific pRB loss results in ectopic cell cycle entry and aberrant ploidy. Cancer Res 2005, 65:4568-4577. 10.1158/0008-5472.CAN-04-4221, 15930274.
48. Lara MF, Garcia-Escudero R, Ruiz S, Santos M, Moral M, Martinez-Cruz AB, Segrelles C, Lorz C, Paramio JM. Gene profiling approaches help to define the specific functions of retinoblastoma family in epidermis. Mol Carcinog 2008, 47:209-221. 10.1002/mc.20376, 17932948.
49. Ruiz S, Santos M, Segrelles C, Leis H, Jorcano JL, Berns A, Paramio JM, Vooijs M. Unique and overlapping functions of pRb and p107 in the control of proliferation and differentiation in epidermis. Development 2004, 131:2737-2748. 10.1242/dev.01148, 15148303.
50. Lee MH, Williams BO, Mulligan G, Mukai S, Bronson RT, Dyson N, Harlow E, Jacks T. Targeted disruption of p107: functional overlap between p107 and Rb. Genes Dev 1996, 10:1621-1632. 10.1101/gad.10.13.1621, 8682293.
51. Cao L, Faha B, Dembski M, Tsai LH, Harlow E, Dyson N. Independent binding of the retinoblastoma protein and p107 to the transcription factor E2F. Nature 1992, 355:176-179. 10.1038/355176a0, 1530885.
52. Zhu L, Heuvel S, Helin K, Fattaey A, Ewen M, Livingston D, Dyson N, Harlow E. Inhibition of cell proliferation by p107, a relative of the retinoblastoma protein. Genes Dev 1993, 7:1111-1125. 10.1101/gad.7.7a.1111, 8319904.
53. Chellappan SP, Hiebert S, Mudryj M, Horowitz JM, Nevins JR. The E2F transcription factor is a cellular target for the RB protein. Cell 1991, 65:1053-1061. 10.1016/0092-8674(91)90557-F, 1828392.
54. Classon M, Dyson N. p107 and p130: versatile proteins with interesting pockets. Exp Cell Res 2001, 264:135-147. 10.1006/excr.2000.5135, 11237530.
55. Xiao ZX, Ginsberg D, Ewen M, Livingston DM. Regulation of the retinoblastoma protein-related protein p107 by G1 cyclin-associated kinases. Proc Natl Acad Sci USA 1996, 93:4633-4637. 10.1073/pnas.93.10.4633, 39330, 8643455.
56. Balciunaite E, Spektor A, Lents NH, Cam H, Te Riele H, Scime A, Rudnicki MA, Young R, Dynlacht BD. Pocket protein complexes are recruited to distinct targets in quiescent and proliferating cells. Mol Cell Biol 2005, 25:8166-8178. 10.1128/MCB.25.18.8166-8178.2005, 1234327, 16135806.
57. Garriga J, Jayaraman AL, Limon A, Jayadeva G, Sotillo E, Truongcao M, Patsialou A, Wadzinski BE, Grana X. A dynamic equilibrium between CDKs and PP2A modulates phosphorylation of pRB, p107 and p130. Cell Cycle 2004, 3:1320-1330.
58. Kolupaeva V, Laplantine E, Basilico C. PP2A-mediated dephosphorylation of p107 plays a critical role in chondrocyte cell cycle arrest by FGF. PLoS One 2008, 3:e3447. 10.1371/journal.pone.0003447, 2562983, 18927618.
59. Voorhoeve PM, Hijmans EM, Bernards R. Functional interaction between a novel protein phosphatase 2A regulatory subunit, PR59, and the retinoblastoma-related p107 protein. Oncogene 1999, 18:515-524. 10.1038/sj.onc.1202316, 9927208.
60. Magnaghi-Jaulin L, Groisman R, Naguibneva I, Robin P, Lorain S, Le Villain JP, Troalen F, Trouche D, Harel-Bellan A. Retinoblastoma protein represses transcription by recruiting a histone deacetylase. Nature 1998, 391:601-605. 10.1038/35410, 9468140.
61. Zhu WG, Seno JD, Beck BD, Dynlacht JR. Translocation of MRE11 from the nucleus to the cytoplasm as a mechanism of radiosensitization by heat. Radiat Res 2001, 156:95-102. 10.1667/0033-7587(2001)156[0095:TOMFTN]2.0.CO;2, 11418077.
62. Vandel L, Nicolas E, Vaute O, Ferreira R, Ait-Si-Ali S, Trouche D. Transcriptional repression by the retinoblastoma protein through the recruitment of a histone methyltransferase. Mol Cell Biol 2001, 21:6484-6494. 10.1128/MCB.21.19.6484-6494.2001, 99795, 11533237.
63. Ferreira R, Magnaghi-Jaulin L, Robin P, Harel-Bellan A, Trouche D. The three members of the pocket proteins family share the ability to repress E2F activity through recruitment of a histone deacetylase. Proc Natl Acad Sci USA 1998, 95:10493-10498. 10.1073/pnas.95.18.10493, 27922, 9724731.
64. Strober BE, Dunaief JL, Guha, Goff SP. Functional interactions between the hBRM/hBRG1 transcriptional activators and the pRB family of proteins. Mol Cell Biol 1996, 16:1576-1583. 231143, 8657132.
65. Yoshimoto T, Boehm M, Olive M, Crook MF, San H, Langenickel T, Nabel EG. The arginine methyltransferase PRMT2 binds RB and regulates E2F function. Exp Cell Res 2006, 312:2040-2053. 10.1016/j.yexcr.2006.03.001, 16616919.
66. Brehm A, Miska EA, McCance DJ, Reid JL, Bannister AJ, Kouzarides T. Retinoblastoma protein recruits histone deacetylase to repress transcription. Nature 1998, 391:597-601. 10.1038/35404, 9468139.
67. Ferreira R, Naguibneva I, Mathieu M, Ait-Si-Ali S, Robin P, Pritchard LL, Harel-Bellan A. Cell cycle-dependent recruitment of HDAC-1 correlates with deacetylation of histone H4 on an Rb-E2F target promoter. EMBO Rep 2001, 2:794-799. 10.1093/embo-reports/kve173, 1084028, 11520855.
68. Dick FA. Structure-function analysis of the retinoblastoma tumor suppressor protein - is the whole a sum of its parts?. Cell Div 2007, 2:26. 10.1186/1747-1028-2-26, 2082274, 17854503.
69. Ross JF, Liu X, Dynlacht BD. Mechanism of transcriptional repression of E2F by the retinoblastoma tumor suppressor protein. Mol Cell 1999, 3:195-205. 10.1016/S1097-2765(00)80310-X, 10078202.
70. Lee EY, Cam H, Ziebold U, Rayman JB, Lees JA, Dynlacht BD. E2F4 loss suppresses tumorigenesis in Rb mutant mice. Cancer Cell 2002, 2:463-472. 10.1016/S1535-6108(02)00207-6, 12498715.
71. Ginsberg D, Vairo G, Chittenden T, Xiao ZX, Xu G, Wydner KL, DeCaprio JA, Lawrence JB, Livingston DM. E2F-4, a new member of the E2F transcription factor family, interacts with p107. Genes Dev 1994, 8:2665-2679. 10.1101/gad.8.22.2665, 7958924.
72. Lindeman GJ, Gaubatz S, Livingston DM, Ginsberg D. The subcellular localization of E2F-4 is cell-cycle dependent. Proc Natl Acad Sci USA 1997, 94:5095-5100. 10.1073/pnas.94.10.5095, 24637, 9144196.
73. Vairo G, Livingston DM, Ginsberg D. Functional interaction between E2F-4 and p130: evidence for distinct mechanisms underlying growth suppression by different retinoblastoma protein family members. Genes Dev 1995, 9:869-881. 10.1101/gad.9.7.869, 7705662.
74. Dyson N, Dembski M, Fattaey A, Ngwu C, Ewen M, Helin K. Analysis of p107-associated proteins: p107 associates with a form of E2F that differs from pRB-associated E2F-1. J Virol 1993, 67:7641-7647. 238233, 8230483.
75. Moberg K, Starz MA, Lees JA. E2F-4 switches from p130 to p107 and pRB in response to cell cycle reentry. Mol Cell Biol 1996, 16:1436-1449. 231128, 8657117.
76. Blais A, Dynlacht BD. E2F-associated chromatin modifiers and cell cycle control. Curr Opin Cell Biol 2007, 19:658-662. 10.1016/j.ceb.2007.10.003, 18023996.
77. Chen CR, Kang Y, Siegel PM, Massague J. E2F4/5 and p107 as Smad cofactors linking the TGFbeta receptor to c-myc repression. Cell 2002, 110:19-32. 10.1016/S0092-8674(02)00801-2, 12150994.
78. Rodier G, Makris C, Coulombe P, Scime A, Nakayama K, Nakayama KI, Meloche S. p107 inhibits G1 to S phase progression by down-regulating expression of the F-box protein Skp2. J Cell Biol 2005, 168:55-66. 10.1083/jcb.200404146, 2171673, 15631990.
79. Hwang HC, Clurman BE. Cyclin E in normal and neoplastic cell cycles. Oncogene 2005, 24:2776-2786. 10.1038/sj.onc.1208613, 15838514.
80. Jiang H, Karnezis AN, Tao M, Guida PM, Zhu L. pRB and p107 have distinct effects when expressed in pRB-deficient tumor cells at physiologically relevant levels. Oncogene 2000, 19:3878-3887. 10.1038/sj.onc.1203722, 10951581.
81. Kondo T, Higashi H, Nishizawa H, Ishikawa S, Ashizawa S, Yamada M, Makita Z, Koike T, Hatakeyama M. Involvement of pRB-related p107 protein in the inhibition of S phase progression in response to genotoxic stress. J Biol Chem 2001, 276:17559-17567. 10.1074/jbc.M009911200, 11278582.
82. Voorhoeve PM, Watson RJ, Farlie PG, Bernards R, Lam EW. Rapid dephosphorylation of p107 following UV irradiation. Oncogene 1999, 18:679-688. 10.1038/sj.onc.1202289, 9989818.
83. Zhu L, Harlow E, Dynlacht BD. p107 uses a p21CIP1-related domain to bind cyclin/cdk2 and regulate interactions with E2F. Genes Dev 1995, 9:1740-1752. 10.1101/gad.9.14.1740, 7622038.
84. Ewen ME, Faha B, Harlow E, Livingston DM. Interaction of p107 with cyclin A independent of complex formation with viral oncoproteins. Science 1992, 255:85-87. 10.1126/science.1532457, 1532457.
85. Faha B, Ewen ME, Tsai LH, Livingston DM, Harlow E. Interaction between human cyclin A and adenovirus E1A-associated p107 protein. Science 1992, 255:87-90. 10.1126/science.1532458, 1532458.
86. Lees E, Faha B, Dulic V, Reed SI, Harlow E. Cyclin E/cdk2 and cyclin A/cdk2 kinases associate with p107 and E2F in a temporally distinct manner. Genes Dev 1992, 6:1874-1885. 10.1101/gad.6.10.1874, 1398067.
87. Zhu L, Enders G, Lees JA, Beijersbergen RL, Bernards R, Harlow E. The pRB-related protein p107 contains two growth suppression domains: independent interactions with E2F and cyclin/cdk complexes. EMBO J 1995, 14:1904-1913. 398289, 7743997.
88. Castano E, Kleyner Y, Dynlacht BD. Dual cyclin-binding domains are required for p107 to function as a kinase inhibitor. Mol Cell Biol 1998, 18:5380-5391. 109123, 9710622.
89. Woo MS, Sanchez I, Dynlacht BD. p130 and p107 use a conserved domain to inhibit cellular cyclin-dependent kinase activity. Mol Cell Biol 1997, 17:3566-3579. 232210, 9199292.
90. Bienvenu F, Jirawatnotai S, Elias JE, Meyer CA, Mizeracka K, Marson A, Frampton GM, Cole MF, Odom DT, Odajima J, et al. Transcriptional role of cyclin D1 in development revealed by a genetic-proteomic screen. Nature 2010, 463:374-378. 10.1038/nature08684, 20090754.
91. Datta PK, Raychaudhuri P, Bagchi S. Association of p107 with Sp1: genetically separable regions of p107 are involved in regulation of E2F- and Sp1-dependent transcription. Mol Cell Biol 1995, 15:5444-5452. 230794, 7565695.
92. Parakati R, DiMario JX. Dynamic transcriptional regulatory complexes, including E2F4, p107, p130, and Sp1, control fibroblast growth factor receptor 1 gene expression during myogenesis. J Biol Chem 2005, 280:21284-21294. 10.1074/jbc.M410744200, 15811856.
93. Joaquin M, Bessa M, Saville MK, Watson RJ. B-Myb overcomes a p107-mediated cell proliferation block by interacting with an N-terminal domain of p107. Oncogene 2002, 21:7923-7932. 10.1038/sj.onc.1206001, 12439743.
94. Beijersbergen RL, Hijmans EM, Zhu L, Bernards R. Interaction of c-Myc with the pRb-related protein p107 results in inhibition of c-Myc-mediated transactivation. EMBO J 1994, 13:4080-4086. 395329, 8076603.
95. Gu W, Bhatia K, Magrath IT, Dang CV, Dalla-Favera R. Binding and suppression of the Myc transcriptional activation domain by p107. Science 1994, 264:251-254. 10.1126/science.8146655, 8146655.
96. De Falco G, Comes F, Simone C. pRb: master of differentiation. Coupling irreversible cell cycle withdrawal with induction of muscle-specific transcription. Oncogene 2006, 25:5244-5249. 10.1038/sj.onc.1209623, 16936743.
97. Lipinski MM, Jacks T. The retinoblastoma gene family in differentiation and development. Oncogene 1999, 18:7873-7882. 10.1038/sj.onc.1203244, 10630640.
98. Nguyen DX, McCance DJ. Role of the retinoblastoma tumor suppressor protein in cellular differentiation. J Cell Biochem 2005, 94:870-879. 10.1002/jcb.20375, 15669057.
99. LeCouter JE, Kablar B, Hardy WR, Ying C, Megeney LA, May LL, Rudnicki MA. Strain-dependent myeloid hyperplasia, growth deficiency, and accelerated cell cycle in mice lacking the Rb-related p107 gene. Mol Cell Biol 1998, 18:7455-7465. 109326, 9819431.
100. Scime A, Grenier G, Huh MS, Gillespie MA, Bevilacqua L, Harper ME, Rudnicki MA. Rb and p107 regulate preadipocyte differentiation into white versus brown fat through repression of PGC-1alpha. Cell Metab 2005, 2:283-295. 10.1016/j.cmet.2005.10.002, 16271529.
101. Ruiz S, Segrelles C, Bravo A, Santos M, Perez P, Leis H, Jorcano JL, Paramio JM. Abnormal epidermal differentiation and impaired epithelial-mesenchymal tissue interactions in mice lacking the retinoblastoma relatives p107 and p130. Development 2003, 130:2341-2353. 10.1242/dev.00453, 12702649.
102. Cobrinik D, Lee MH, Hannon G, Mulligan G, Bronson RT, Dyson N, Harlow E, Beach D, Weinberg RA, Jacks T. Shared role of the pRB-related p130 and p107 proteins in limb development. Genes Dev 1996, 10:1633-1644. 10.1101/gad.10.13.1633, 8682294.
103. Yeh N, Miller JP, Gaur T, Capellini TD, Nikolich-Zugich J, de la Hoz C, Selleri L, Bromage TG, van Wijnen AJ, Stein GS, et al. Cooperation between p27 and p107 during endochondral ossification suggests a genetic pathway controlled by p27 and p130. Mol Cell Biol 2007, 27:5161-5171. 10.1128/MCB.02431-06, 1951950, 17502351.
104. Laplantine E, Rossi F, Sahni M, Basilico C, Cobrinik D. FGF signaling targets the pRb-related p107 and p130 proteins to induce chondrocyte growth arrest. J Cell Biol 2002, 158:741-750. 10.1083/jcb.200205025, 2174007, 12177046.
105. Vanderluit JL, Ferguson KL, Nikoletopoulou V, Parker M, Ruzhynsky V, Alexson T, McNamara SM, Park DS, Rudnicki M, Slack RS. p107 regulates neural precursor cells in the mammalian brain. J Cell Biol 2004, 166:853-863. 10.1083/jcb.200403156, 2172121, 15353549.
106. Jiang Z, Zacksenhaus E, Gallie BL, Phillips RA. The retinoblastoma gene family is differentially expressed during embryogenesis. Oncogene 1997, 14:1789-1797. 10.1038/sj.onc.1201014, 9150384.
107. Yoshikawa K. Cell cycle regulators in neural stem cells and postmitotic neurons. Neurosci Res 2000, 37:1-14. 10.1016/S0168-0102(00)00101-2, 10802339.
108. Vanderluit JL, Wylie CA, McClellan KA, Ghanem N, Fortin A, Callaghan S, MacLaurin JG, Park DS, Slack RS. The Retinoblastoma family member p107 regulates the rate of progenitor commitment to a neuronal fate. J Cell Biol 2007, 178:129-139. 10.1083/jcb.200703176, 2064429, 17591923.
109. Raballo R, Rhee J, Lyn-Cook R, Leckman JF, Schwartz ML, Vaccarino FM. Basic fibroblast growth factor (Fgf2) is necessary for cell proliferation and neurogenesis in the developing cerebral cortex. J Neurosci 2000, 20:5012-5023.
110. Gritti A, Parati EA, Cova L, Frolichsthal P, Galli R, Wanke E, Faravelli L, Morassutti DJ, Roisen F, Nickel DD, Vescovi AL. Multipotential stem cells from the adult mouse brain proliferate and self-renew in response to basic fibroblast growth factor. J Neurosci 1996, 16:1091-1100.
111. Kilpatrick TJ, Bartlett PF. Cloned multipotential precursors from the mouse cerebrum require FGF-2, whereas glial restricted precursors are stimulated with either FGF-2 or EGF. J Neurosci 1995, 15:3653-3661.
112. McClellan KA, Vanderluit JL, Julian LM, Andrusiak MG, Dugal-Tessier D, Park DS, Slack RS. The p107/E2F pathway regulates fibroblast growth factor 2 responsiveness in neural precursor cells. Mol Cell Biol 2009, 29:4701-4713. 10.1128/MCB.01767-08, 2725701, 19564414.
113. Marino S, Hoogervoorst D, Brandner S, Berns A. Rb and p107 are required for normal cerebellar development and granule cell survival but not for Purkinje cell persistence. Development 2003, 130:3359-3368. 10.1242/dev.00553, 12810584.
114. Batsche E, Moschopoulos P, Desroches J, Bilodeau S, Drouin J. Retinoblastoma and the related pocket protein p107 act as coactivators of NeuroD1 to enhance gene transcription. J Biol Chem 2005, 280:16088-16095. 10.1074/jbc.M413427200, 15701640.
115. Gao Z, Ure K, Ables JL, Lagace DC, Nave KA, Goebbels S, Eisch AJ, Hsieh J. Neurod1 is essential for the survival and maturation of adult-born neurons. Nat Neurosci 2009, 12:1090-1092. 10.1038/nn.2385, 19701197.
116. Beroukhim R, Mermel CH, Porter D, Wei G, Raychaudhuri S, Donovan J, Barretina J, Boehm JS, Dobson J, Urashima M, et al. The landscape of somatic copy-number alteration across human cancers. Nature 2010, 463:899-905. 10.1038/nature08822, 20164920.
117. Asimakopoulos FA, White NJ, Nacheva E, Green AR. Molecular analysis of chromosome 20q deletions associated with myeloproliferative disorders and myelodysplastic syndromes. Blood 1994, 84:3086-3094.
118. Ichimura K, Hanafusa H, Takimoto H, Ohgama Y, Akagi T, Shimizu K. Structure of the human retinoblastoma-related p107 gene and its intragenic deletion in a B-cell lymphoma cell line. Gene 2000, 251:37-43. 10.1016/S0378-1119(00)00193-1, 10863094.
119. Pei XH, Xiong Y. Biochemical and cellular mechanisms of mammalian CDK inhibitors: a few unresolved issues. Oncogene 2005, 24:2787-2795. 10.1038/sj.onc.1208611, 15838515.
120. Canepa ET, Scassa ME, Ceruti JM, Marazita MC, Carcagno AL, Sirkin PF, Ogara MF. INK4 proteins, a family of mammalian CDK inhibitors with novel biological functions. IUBMB Life 2007, 59:419-426. 10.1080/15216540701488358, 17654117.
121. Mulligan G, Jacks T. The retinoblastoma gene family: cousins with overlapping interests. Trends Genet 1998, 14:223-229. 10.1016/S0168-9525(98)01470-X, 9635405.
122. Lara MF, Santos M, Ruiz S, Segrelles C, Moral M, Martinez-Cruz AB, Hernandez P, Martinez-Palacio J, Lorz C, Garcia-Escudero R, Paramio JM. p107 acts as a tumor suppressor in pRb-deficient epidermis. Mol Carcinog 2008, 47:105-113. 10.1002/mc.20367, 17932945.
123. Santos M, Ruiz S, Lara MF, Segrelles C, Moral M, Martinez-Cruz AB, Ballestin C, Lorz C, Garcia-Escudero R, Paramio JM. Susceptibility of pRb-deficient epidermis to chemical skin carcinogenesis is dependent on the p107 allele dosage. Mol Carcinog 2008, 47:815-821. 10.1002/mc.20426, 18300254.
124. Viatour P, Somervaille TC, Venkatasubrahmanyam S, Kogan S, McLaughlin ME, Weissman IL, Butte AJ, Passegue E, Sage J. Hematopoietic stem cell quiescence is maintained by compound contributions of the retinoblastoma gene family. Cell Stem Cell 2008, 3:416-428. 10.1016/j.stem.2008.07.009, 2646421, 18940733.
125. Macpherson D. Insights from mouse models into human retinoblastoma. Cell Div 2008, 3:9. 10.1186/1747-1028-3-9, 2430952, 18489754.
126. Simpson DS, Mason-Richie NA, Gettler CA, Wikenheiser-Brokamp KA. Retinoblastoma family proteins have distinct functions in pulmonary epithelial cells in vivo critical for suppressing cell growth and tumorigenesis. Cancer Res 2009, 69:8733-8741. 10.1158/0008-5472.CAN-09-1359, 19887614.
127. Donovan SL, Schweers B, Martins R, Johnson D, Dyer MA. Compensation by tumor suppressor genes during retinal development in mice and humans. BMC Biol 2006, 4:14. 10.1186/1741-7007-4-14, 1481602, 16672052.
128. Kwartz AJ, Henson DB, Harper RA, Spencer AF, McLeod D. The effectiveness of the Heidelberg Retina Tomograph and laser diagnostic glaucoma scanning system (GDx) in detecting and monitoring glaucoma. Health Technol Assess 2005, 9:1-132.
129. MacPherson D, Sage J, Kim T, Ho D, McLaughlin ME, Jacks T. Cell type-specific effects of Rb deletion in the murine retina. Genes Dev 2004, 18:1681-1694. 10.1101/gad.1203304, 478190, 15231717.
130. Dannenberg JH, Schuijff L, Dekker M, Valk M, te Riele H. Tissue-specific tumor suppressor activity of retinoblastoma gene homologs p107 and p130. Genes Dev 2004, 18:2952-2962. 10.1101/gad.322004, 534655, 15574596.
131. MacPherson D, Conkrite K, Tam M, Mukai S, Mu D, Jacks T. Murine bilateral retinoblastoma exhibiting rapid-onset, metastatic progression and N-myc gene amplification. EMBO J 2007, 26:784-794. 10.1038/sj.emboj.7601515, 1794380, 17235288.
132. Johnson DA, Zhang J, Frase S, Wilson M, Rodriguez-Galindo C, Dyer MA. Neuronal differentiation and synaptogenesis in retinoblastoma. Cancer Res 2007, 67:2701-2711. 10.1158/0008-5472.CAN-06-3754, 17363591.
133. Ajioka I, Martins RA, Bayazitov IT, Donovan S, Johnson DA, Frase S, Cicero SA, Boyd K, Zakharenko SS, Dyer MA. Differentiated horizontal interneurons clonally expand to form metastatic retinoblastoma in mice. Cell 2007, 131:378-390. 10.1016/j.cell.2007.09.036, 2203617, 17956737.
134. Plesca D, Crosby ME, Gupta D, Almasan A. E2F4 function in G2: maintaining G2-arrest to prevent mitotic entry with damaged DNA. Cell Cycle 2007, 6:1147-1152. 2596058, 17507799.
135. Stark GR, Taylor WR. Control of the G2/M transition. Mol Biotechnol 2006, 32:227-248. 10.1385/MB:32:3:227, 16632889.
136. Sun A, Bagella L, Tutton S, Romano G, Giordano A. From G0 to S phase: a view of the roles played by the retinoblastoma (Rb) family members in the Rb-E2F pathway. J Cell Biochem 2007, 102:1400-1404. 10.1002/jcb.21609, 17979151.
137. Sol Genomics Network. , http://solgenomics.net/
138. Scheijen B, Bronk M, Meer T, Bernards R. Constitutive E2F1 overexpression delays endochondral bone formation by inhibiting chondrocyte differentiation. Mol Cell Biol 2003, 23:3656-3668. 10.1128/MCB.23.10.3656-3668.2003, 164752, 12724423.
139. Rossi F, MacLean HE, Yuan W, Francis RO, Semenova E, Lin CS, Kronenberg HM, Cobrinik D. p107 and p130 Coordinately regulate proliferation, Cbfa1 expression, and hypertrophic differentiation during endochondral bone development. Dev Biol 2002, 247:271-285. 10.1006/dbio.2002.0691, 12086466.
140. Shirodkar S, Ewen M, DeCaprio JA, Morgan J, Livingston DM, Chittenden T. The transcription factor E2F interacts with the retinoblastoma product and a p107-cyclin A complex in a cell cycle-regulated manner. Cell 1992, 68:157-166. 10.1016/0092-8674(92)90214-W, 1531040.
141. Zhang J, Schweers B, Dyer MA. The first knockout mouse model of retinoblastoma. Cell Cycle 2004, 3:952-959.
142. Berman SD, West JC, Danielian PS, Caron AM, Stone JR, Lees JA. Mutation of p107 exacerbates the consequences of Rb loss in embryonic tissues and causes cardiac and blood vessel defects. Proc Natl Acad Sci USA 2009, 106:14932-14936. 10.1073/pnas.0902408106, 2736449, 19706423.
143. Chen D, Livne-bar I, Vanderluit JL, Slack RS, Agochiya M, Bremner R. Cell-specific effects of RB or RB/p107 loss on retinal development implicate an intrinsically death-resistant cell-of-origin in retinoblastoma. Cancer Cell 2004, 5:539-551. 10.1016/j.ccr.2004.05.025, 15193257.